Novel humanized anti-Nav1.7 antibodies with long-lasting, side-effect-free analgesic effects
Sosuke Yoneda, Daisuke Uta, Kana Yasufuku, Takuya Yamane, Saho Yoshioka, Keiko Takasu, Takaya Izumi, Sayaka Fujita, Daiki Nakamori, Shiori Kawasaki, Tatsuya Takahashi, Mai Yoshikawa, Koichi Ogawa, Erika Kasai
This study develops humanized anti-Nav1.7 antibodies that show long-lasting analgesic effects without side effects in neuropathic pain models.
bioRxiv · Aug 22, 2025 · PreprintPharmacology & Toxicology